Sfoglia per Autore
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma
2002-01-01 M., Offidani; A., Mele; L., Corvatta; M., Marconi; L., Malerba; Olivieri, Attilio; S., Rupoli; F., Alesiani; Leoni, Pietro
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.
2002-01-01 Offidani, M; Mele, A; Corvatta, L; Marconi, M; Malerba, L; Olivieri, Attilio; Rupoli, S; Alesiani, F; Leoni, Pietro
Long term results of a Multicenter study of autologous selected-PBSC transplantation in advanced CLL patients.
2002-01-01 Scime, R; Tringali, S; Santoro, A; Di Bella, R; Cavallaro, A; Majolino, I; Musso, M; Olivieri, Attilio; Narni, F; Iacopino, P; Leoni, Pietro; Basirico, R; Mirto, S.
Cytomegalovirus infection in cancer patients receiving granulocyte transfusions
2002-01-01 Corradini, P.; Tarella, C.; Olivieri, Attilio; Gianni, A. M.; Voena, C.; Zallio, F.; Ladetto, M.; Falda, M.; Lucesole, M.; Dodero, A.; Ciceri, F.; Benedetti, F.; Rambaldi, A.; Sajeva, M. R.; Tresoldi, M.; Pileri, A.; Bordignon, C.; Bregni, M.
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80°
2002-01-01 Montanari, M; Capelli, D; Spitaleri, G; Offidani, M; Poloni, Antonella; Lucesole, M; Massidda, D; Masia, M; Tonnini, Maria Cecilia; Balducci, F; Leoni, Pietro; Olivieri, Attilio
Vacop-B vs Vacop-B plus high-dose sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma (NHL)
2002-01-01 Santini, G; Congiu, A; Olivieri, Attilio; Malolino, I; Chisesi, T; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V.
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C
2002-01-01 Montanari, M; Capelli, D; Spitaleri, L; Gini, G; Offidani, M; Poloni, Antonella; Lucesole, M; Massidda, D; Masia, M; Tonnini, Maria Cecilia; Balducci, F; Leoni, Pietro; Olivieri, Attilio
Reduced-intensity conditioning followed by allogeneic transplantation (HSCT) is an effective salvage treatment for both low- and high-grade non-Hodgkin lymphomas: Disease chemosensitivity has a major impact on outcome.
2002-01-01 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, Em; Rambaldi, A; Majolino, I; Soligo, D; Scime, R; Gianni, Am
Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need.
2002-01-01 Olivieri, Attilio; Spitaleri, L; Gini, G; Montanari, M; Capelli, D; Lucesole, M; Scortechini, I; Poloni, Antonella; Pasquini, R; Masia, Mc; Leoni, Pietro
Kinetics of immune reconstitution and incidence of infections following allogeneic peripheral blood stem cell transplantation (PBSCT) in patients conditioned with a reduced-intensity regimen
2002-01-01 Dodero, A; Peccatori, J; Olivieri, Attilio; Pescarollo, A; Ferreri, A; Rossini, S; Gianni, Am; Bordignon, C; Bregni, M; Corradini, P.
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis.
2002-01-01 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, M; Musso, M; Callea, V; Gallamini, A; Patti, C; Pavone, V; Almici, C; Di Raimondo, F; Fioritoni, G; Olivieri, Attilio; Pogliani, Em; De Souza, Ca; Majolino, I; Boccadoro, M; Gianni, Am; Pileri, A; Corradini, P; Tarella, C.
Factors affecting acute toxicity in 294 autologous transplant procedures: a single center multivariate analysis
2002-01-01 Capelli, D; Montanari, M; Spitaleri, L; Pennacchioni, M; Candela, M; Centurioni, R; Poloni, Antonella; Lucesole, M; Gini, G; Massidda, D; Leoni, Pietro; Olivieri, Attilio
Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma.
2002-01-01 Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M.
In multiple myeloma (MM) allogeneic PBSC transplantation results in high rate of remission and low rate of recurrence.
2002-01-01 Majolino, I; Corradini, P; Santoro, A; Scime, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marceno, R; Pileri, A.
Reduced-intensity conditioning followed by allogeneic transplantation is an effective salvage treatment for patients with hematologic malignancies failing a previous autograft
2002-01-01 Corradini, P; Tarella, C; Olivieri, Attilio; Dodero, A; Voena, C; Leoni, Pietro; Zallio, F; Ciceri, F; Devizzi, L; Rambaldi, A; Sajeva, M; Bordignon, C; Gianni, A; Bregni, M.
Transplant-related mortality (TRM) in patients receving reduced vs conventional intensity thiotepa-cyclophosphamide (THIO-CY) conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT)
2002-01-01 Busca, A; Bosi, A; Van Lint, M; Guidi, S; Faida, M; Locatelli, F; Tarella, C; Corradini, P; Olivieri, Attilio; Lucesole, M; Pioltelli, F; Pogliani, E; Rotoli, B; Bacigalupo, A.
Salvage therapy with rituximab plus GM-CSF and CHOP is effective in lymphoma patients relapsed after auto PBSC transplant. Interim analysis from open prospective study in 25 patients
2002-01-01 Olivieri, Attilio; Lucesole, M; Spitaleri, L; Gini, G; Capelli, D; Montanari, M; Poloni, Antonella; Congiu, M; Centurioni, R; Candela, M; Giachetti, R; Leoni, Pietro
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
2002-01-01 Corradini, P; Tarella, C; Olivieri, Attilio; Gianni, Am; Voena, C; Zallio, F; Ladetto, M; Falda, M; Lucesole, M; Dodero, A; Ciceri, F; Benedetti, F; Rambaldi, A; Sajeva, Mr; Tresoldi, M; Pileri, A; Bordignon, C; Bregni, M.
LONG-TERM HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION: A COMPARISON BETWEEN CONTROLLED-RATE FREEZING AND UNCONTROLLED-RATE FREEZING AT 80 DEGREES C
2003-01-01 Montanari, M; Capelli, D; Poloni, Antonella; Massidda, D; Brunori, M; Spitaleri, L; Offidani, M; Lucesole, M; Masia, Mc; Balducci, F; Refe, C; Piani, M; Leoni, Pietro; Olivieri, Attilio
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study
2003-01-01 Offidani, M; Marconi, M; Corvatta, L; Olivieri, Attilio; Catarini, M; Leoni, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma | 1-gen-2002 | M., Offidani; A., Mele; L., Corvatta; M., Marconi; L., Malerba; Olivieri, Attilio; S., Rupoli; F., Alesiani; Leoni, Pietro | |
| Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma. | 1-gen-2002 | Offidani, M; Mele, A; Corvatta, L; Marconi, M; Malerba, L; Olivieri, Attilio; Rupoli, S; Alesiani, F; Leoni, Pietro | |
| Long term results of a Multicenter study of autologous selected-PBSC transplantation in advanced CLL patients. | 1-gen-2002 | Scime, R; Tringali, S; Santoro, A; Di Bella, R; Cavallaro, A; Majolino, I; Musso, M; Olivieri, Attilio; Narni, F; Iacopino, P; Leoni, Pietro; Basirico, R; Mirto, S. | |
| Cytomegalovirus infection in cancer patients receiving granulocyte transfusions | 1-gen-2002 | Corradini, P.; Tarella, C.; Olivieri, Attilio; Gianni, A. M.; Voena, C.; Zallio, F.; Ladetto, M.; Falda, M.; Lucesole, M.; Dodero, A.; Ciceri, F.; Benedetti, F.; Rambaldi, A.; Sajeva, M. R.; Tresoldi, M.; Pileri, A.; Bordignon, C.; Bregni, M. | |
| Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° | 1-gen-2002 | Montanari, M; Capelli, D; Spitaleri, G; Offidani, M; Poloni, Antonella; Lucesole, M; Massidda, D; Masia, M; Tonnini, Maria Cecilia; Balducci, F; Leoni, Pietro; Olivieri, Attilio | |
| Vacop-B vs Vacop-B plus high-dose sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma (NHL) | 1-gen-2002 | Santini, G; Congiu, A; Olivieri, Attilio; Malolino, I; Chisesi, T; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V. | |
| Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C | 1-gen-2002 | Montanari, M; Capelli, D; Spitaleri, L; Gini, G; Offidani, M; Poloni, Antonella; Lucesole, M; Massidda, D; Masia, M; Tonnini, Maria Cecilia; Balducci, F; Leoni, Pietro; Olivieri, Attilio | |
| Reduced-intensity conditioning followed by allogeneic transplantation (HSCT) is an effective salvage treatment for both low- and high-grade non-Hodgkin lymphomas: Disease chemosensitivity has a major impact on outcome. | 1-gen-2002 | Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, Em; Rambaldi, A; Majolino, I; Soligo, D; Scime, R; Gianni, Am | |
| Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need. | 1-gen-2002 | Olivieri, Attilio; Spitaleri, L; Gini, G; Montanari, M; Capelli, D; Lucesole, M; Scortechini, I; Poloni, Antonella; Pasquini, R; Masia, Mc; Leoni, Pietro | |
| Kinetics of immune reconstitution and incidence of infections following allogeneic peripheral blood stem cell transplantation (PBSCT) in patients conditioned with a reduced-intensity regimen | 1-gen-2002 | Dodero, A; Peccatori, J; Olivieri, Attilio; Pescarollo, A; Ferreri, A; Rossini, S; Gianni, Am; Bordignon, C; Bregni, M; Corradini, P. | |
| Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis. | 1-gen-2002 | Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, M; Musso, M; Callea, V; Gallamini, A; Patti, C; Pavone, V; Almici, C; Di Raimondo, F; Fioritoni, G; Olivieri, Attilio; Pogliani, Em; De Souza, Ca; Majolino, I; Boccadoro, M; Gianni, Am; Pileri, A; Corradini, P; Tarella, C. | |
| Factors affecting acute toxicity in 294 autologous transplant procedures: a single center multivariate analysis | 1-gen-2002 | Capelli, D; Montanari, M; Spitaleri, L; Pennacchioni, M; Candela, M; Centurioni, R; Poloni, Antonella; Lucesole, M; Gini, G; Massidda, D; Leoni, Pietro; Olivieri, Attilio | |
| Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma. | 1-gen-2002 | Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M. | |
| In multiple myeloma (MM) allogeneic PBSC transplantation results in high rate of remission and low rate of recurrence. | 1-gen-2002 | Majolino, I; Corradini, P; Santoro, A; Scime, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marceno, R; Pileri, A. | |
| Reduced-intensity conditioning followed by allogeneic transplantation is an effective salvage treatment for patients with hematologic malignancies failing a previous autograft | 1-gen-2002 | Corradini, P; Tarella, C; Olivieri, Attilio; Dodero, A; Voena, C; Leoni, Pietro; Zallio, F; Ciceri, F; Devizzi, L; Rambaldi, A; Sajeva, M; Bordignon, C; Gianni, A; Bregni, M. | |
| Transplant-related mortality (TRM) in patients receving reduced vs conventional intensity thiotepa-cyclophosphamide (THIO-CY) conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) | 1-gen-2002 | Busca, A; Bosi, A; Van Lint, M; Guidi, S; Faida, M; Locatelli, F; Tarella, C; Corradini, P; Olivieri, Attilio; Lucesole, M; Pioltelli, F; Pogliani, E; Rotoli, B; Bacigalupo, A. | |
| Salvage therapy with rituximab plus GM-CSF and CHOP is effective in lymphoma patients relapsed after auto PBSC transplant. Interim analysis from open prospective study in 25 patients | 1-gen-2002 | Olivieri, Attilio; Lucesole, M; Spitaleri, L; Gini, G; Capelli, D; Montanari, M; Poloni, Antonella; Congiu, M; Centurioni, R; Candela, M; Giachetti, R; Leoni, Pietro | |
| Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies | 1-gen-2002 | Corradini, P; Tarella, C; Olivieri, Attilio; Gianni, Am; Voena, C; Zallio, F; Ladetto, M; Falda, M; Lucesole, M; Dodero, A; Ciceri, F; Benedetti, F; Rambaldi, A; Sajeva, Mr; Tresoldi, M; Pileri, A; Bordignon, C; Bregni, M. | |
| LONG-TERM HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION: A COMPARISON BETWEEN CONTROLLED-RATE FREEZING AND UNCONTROLLED-RATE FREEZING AT 80 DEGREES C | 1-gen-2003 | Montanari, M; Capelli, D; Poloni, Antonella; Massidda, D; Brunori, M; Spitaleri, L; Offidani, M; Lucesole, M; Masia, Mc; Balducci, F; Refe, C; Piani, M; Leoni, Pietro; Olivieri, Attilio | |
| Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study | 1-gen-2003 | Offidani, M; Marconi, M; Corvatta, L; Olivieri, Attilio; Catarini, M; Leoni, Pietro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile